Skip to main content
UniHealth

Doctor search

Ana Carolina Tesi Rocha, MD

Neuromuscular Medicine · Palo Alto

NPI 1255646915

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
13
2 carriers
Office
1

Offices

1 location

Plans that list them

13 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Rocha’s office at (202) 476-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

13 of 13 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
Anthem Full Dual Advantage Aligned (HMO D-SNP)Anthem Blue CrossListedOct 3, 2026

California Medical Board record

Licence A125750 · Current

Licensed to practise in California · since 2013 · expires 2028-09-30 · University of Buenos Aires Faculty of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Medicaid work

$19,069 in 2024

Medicaid paid $19,069 for 126 billed services this clinician did in 2024, up to 23 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Long return visit (40+ min)113$18,177
Prolonged outpatient evaluation and management service(s) time with or without direct patient contact beyond the required time of the primary service when the primary service level has been selected using total time, each 15 minutes of total time (List separately in addition to the code of the outpatient Evaluation and Management service)13$892
Medicaid work by year
2024126223$19,069
2023177322$23,685
2022120223$16,017
2021177324$21,166
202055214$6,477
201996218$9,748
201896225$9,558
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Long return visit (40+ min)132$20,256
Return visit (30+ min)16$1,821
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES29$1,607

2022

Largest Medicaid services in 2022
Long return visit (40+ min)107$15,643
Prolonged outpatient evaluation and management service(s) time with or without direct patient contact beyond the required time of the primary service when the primary service level has been selected using total time, each 15 minutes of total time (List separately in addition to the code of the outpatient Evaluation and Management service)13$374

2021

Largest Medicaid services in 2021
Long return visit (40+ min)123$17,238
Prolonged outpatient evaluation and management service(s) time with or without direct patient contact beyond the required time of the primary service when the primary service level has been selected using total time, each 15 minutes of total time (List separately in addition to the code of the outpatient Evaluation and Management service)41$2,411
Return visit (30+ min)13$1,517

2020

Largest Medicaid services in 2020
Long return visit (40+ min)43$5,389
Return visit (30+ min)12$1,089

2019

Largest Medicaid services in 2019
Return visit (30+ min)79$8,053
OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES17$1,695

2018

Largest Medicaid services in 2018
Return visit (30+ min)81$7,520
OFF/OP CNSLTJ NEW/EST MOD 4015$2,037

Money from drug and device companies

$35,359 in 2025

Industry payments by year
2025733$31,467$35,359
2024318$17,085$19,095
2023417$14,480$17,691
2022431$29,105$32,875
2021210$19,992$19,992
202046$6,425$6,570
2019221$20,783$22,842

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Sarepta TherapeuticsElevidys$11,907
11 payments
  • Meals · 2025-07-28 · $100
  • Consulting for Elevidys · 2025-07-09 · $10,000
  • Meals for Elevidys · 2025-06-14 · $34
  • Meals for Elevidys · 2025-06-14 · $34
  • Meals for Elevidys · 2025-06-14 · $46
  • Meals for Elevidys · 2025-06-14 · $50
  • Travel for Elevidys · 2025-06-14 · $196
  • Travel for Elevidys · 2025-06-13 · $257
  • Travel for Elevidys · 2025-06-13 · $318
  • Travel for Elevidys · 2025-06-13 · $729
  • Meals · 2025-01-15 · $142
Janssen Scientific AffairsNone$7,559
7 payments
  • Consulting · 2025-12-20 · $6,400
  • Meals · 2025-12-13 · $41
  • Meals · 2025-12-13 · $40
  • Meals · 2025-12-13 · $37
  • Travel · 2025-12-12 · $181
  • Travel · 2025-12-12 · $198
  • Travel · 2025-12-12 · $662
BiogenNone$7,010
4 payments
  • Travel · 2025-12-10 · $129
  • Travel · 2025-12-10 · $123
  • Consulting · 2025-12-10 · $3,083
  • Consulting · 2025-12-04 · $3,675
ITF TherapeuticsNone$5,310
3 payments
  • Consulting · 2025-06-26 · $1,200
  • Consulting · 2025-04-03 · $600
  • Consulting · 2025-01-17 · $3,510
Catalyst PharmaceuticalsAgamree$3,529
6 payments
  • Travel for Agamree · 2025-11-11 · $116
  • Travel for Agamree · 2025-11-11 · $106
  • Meals for Agamree · 2025-11-11 · $24
  • Honoraria for Agamree · 2025-11-11 · $2,400
  • Travel for Agamree · 2025-10-31 · $283
  • Honoraria for Agamree · 2025-05-05 · $599
Novartis PharmaceuticalsZolgensma$38
1 payment
  • Meals for Zolgensma · 2025-06-26 · $38
See all 33 published payments
Every published payment
Janssen Scientific AffairsConsulting · 2025-12-20None$6,400
Janssen Scientific AffairsMeals · 2025-12-13None$41
Janssen Scientific AffairsMeals · 2025-12-13None$40
Janssen Scientific AffairsMeals · 2025-12-13None$37
Janssen Scientific AffairsTravel · 2025-12-12None$181
Janssen Scientific AffairsTravel · 2025-12-12None$198
Janssen Scientific AffairsTravel · 2025-12-12None$662
BiogenTravel · 2025-12-10None$129
BiogenTravel · 2025-12-10None$123
BiogenConsulting · 2025-12-10None$3,083
BiogenConsulting · 2025-12-04None$3,675
Catalyst PharmaceuticalsTravel · 2025-11-11Agamree$116
Catalyst PharmaceuticalsTravel · 2025-11-11Agamree$106
Catalyst PharmaceuticalsMeals · 2025-11-11Agamree$24
Catalyst PharmaceuticalsHonoraria · 2025-11-11Agamree$2,400
Catalyst PharmaceuticalsTravel · 2025-10-31Agamree$283
Janssen BiotechMeals · 2025-09-05None$6
Sarepta TherapeuticsMeals · 2025-07-28None$100
Sarepta TherapeuticsConsulting · 2025-07-09Elevidys$10,000
Novartis PharmaceuticalsMeals · 2025-06-26Zolgensma$38
ITF TherapeuticsConsulting · 2025-06-26None$1,200
Sarepta TherapeuticsMeals · 2025-06-14Elevidys$34
Sarepta TherapeuticsMeals · 2025-06-14Elevidys$34
Sarepta TherapeuticsMeals · 2025-06-14Elevidys$46
Sarepta TherapeuticsMeals · 2025-06-14Elevidys$50
Sarepta TherapeuticsTravel · 2025-06-14Elevidys$196
Sarepta TherapeuticsTravel · 2025-06-13Elevidys$257
Sarepta TherapeuticsTravel · 2025-06-13Elevidys$318
Sarepta TherapeuticsTravel · 2025-06-13Elevidys$729
Catalyst PharmaceuticalsHonoraria · 2025-05-05Agamree$599
ITF TherapeuticsConsulting · 2025-04-03None$600
ITF TherapeuticsConsulting · 2025-01-17None$3,510
Sarepta TherapeuticsMeals · 2025-01-15None$142
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $19,095

Payments by company in 2024
Sarepta TherapeuticsElevidys$11,845
15 payments
  • Travel for Elevidys · 2024-10-09 · $21
  • Meals for Elevidys · 2024-10-09 · $58
  • Travel for Elevidys · 2024-10-09 · $59
  • Consulting for Elevidys · 2024-10-09 · $10,000
  • Meals for Elevidys · 2024-09-14 · $38
  • Meals for Elevidys · 2024-09-14 · $41
  • Meals for Elevidys · 2024-09-14 · $50
  • Meals for Elevidys · 2024-09-14 · $64
  • Travel for Elevidys · 2024-09-14 · $250
  • Travel for Elevidys · 2024-09-13 · $238
  • Travel for Elevidys · 2024-09-13 · $254
  • Travel for Elevidys · 2024-09-13 · $476
  • Meals · 2024-05-08 · $85
  • Travel · 2024-03-03 · $84
  • Meals · 2024-03-03 · $127
Novartis PharmaceuticalsZolgensma$7,085
1 payment
  • Consulting for Zolgensma · 2024-10-19 · $7,085
Novartis Gene Therapies Inc. (fka Avexis Inc.)Zolgensma$165
2 payments
  • Meals for Zolgensma · 2024-06-06 · $105
  • Meals for Zolgensma · 2024-03-03 · $60

2023: $17,691

Payments by company in 2023
Sarepta TherapeuticsNone$10,147
9 payments
  • Travel · 2023-11-30 · $21
  • Travel · 2023-11-30 · $60
  • Meals · 2023-11-30 · $100
  • Consulting · 2023-11-23 · $8,525
  • Travel · 2023-11-04 · $299
  • Travel · 2023-11-04 · $404
  • Travel · 2023-11-04 · $534
  • Meals · 2023-07-10 · $90
  • Meals · 2023-03-20 · $115
Novartis Gene Therapies Inc. (fka AveXis Inc.)Zolgensma$7,283
6 payments
  • Meals for Zolgensma · 2023-09-13 · $81
  • Honoraria for Zolgensma · 2023-09-13 · $5,955
  • Travel for Zolgensma · 2023-09-13 · $83
  • Travel for Zolgensma · 2023-08-26 · $696
  • Meals for Zolgensma · 2023-08-25 · $33
  • Travel for Zolgensma · 2023-08-08 · $434
GenentechEnspryng$143
1 payment
  • Meals for Enspryng · 2023-09-22 · $143
GenzymeNone$117
1 payment
  • Meals · 2023-05-17 · $117

2022: $32,875

Payments by company in 2022
Sarepta TherapeuticsExondys 51$14,167
19 payments
  • Consulting · 2022-12-01 · $650
  • Meals for Exondys 51 · 2022-11-03 · $4
  • Meals for Exondys 51 · 2022-10-14 · $21
  • Meals · 2022-09-10 · $37
  • Meals · 2022-09-10 · $50
  • Meals · 2022-09-10 · $50
  • Travel · 2022-09-10 · $62
  • Meals · 2022-09-10 · $150
  • Travel · 2022-09-10 · $159
  • Travel · 2022-09-10 · $350
  • Travel · 2022-09-10 · $1,291
  • Consulting · 2022-08-12 · $500
  • Consulting · 2022-04-18 · $9,500
  • Meals · 2022-04-09 · $50
  • Meals · 2022-04-09 · $50
  • Travel · 2022-04-09 · $249
  • Travel · 2022-04-09 · $350
  • Travel · 2022-04-09 · $533
  • Meals · 2022-01-05 · $110
BiogenSpinraza$13,883
9 payments
  • Consulting · 2022-12-21 · $2,470
  • Consulting · 2022-10-22 · $1,853
  • Consulting for Spinraza · 2022-10-14 · $1,729
  • Consulting for Spinraza · 2022-06-22 · $6,546
  • Meals for Spinraza · 2022-06-15 · $136
  • Travel for Spinraza · 2022-06-15 · $45
  • Paid to speak or teach for Spinraza · 2022-01-12 · $234
  • Paid to speak or teach for Spinraza · 2022-01-12 · $720
  • Paid to speak or teach · 2022-01-12 · $151
Novartis Gene Therapies Inc. (fka AveXis Inc.)Zolgensma$2,543
1 payment
  • Honoraria for Zolgensma · 2022-04-27 · $2,543
NS PharmaViltepso$2,282
2 payments
  • Meals for Viltepso · 2022-08-18 · $72
  • Honoraria for Viltepso · 2022-03-31 · $2,210

2021: $19,992

Payments by company in 2021
Sarepta TherapeuticsNone$12,280
3 payments
  • Consulting · 2021-08-09 · $3,000
  • Consulting · 2021-03-15 · $3,500
  • Consulting · 2021-01-20 · $5,780
BiogenSpinraza$7,712
7 payments
  • Consulting · 2021-10-29 · $960
  • Consulting · 2021-10-12 · $420
  • Paid to speak or teach for Spinraza · 2021-10-12 · $2,000
  • Paid to speak or teach for Spinraza · 2021-10-12 · $649
  • Consulting · 2021-09-23 · $504
  • Paid to speak or teach for Spinraza · 2021-09-23 · $2,400
  • Paid to speak or teach for Spinraza · 2021-09-23 · $779

2020: $6,570

Payments by company in 2020
BiogenSpinraza$3,840
2 payments
  • Consulting for Spinraza · 2020-12-17 · $1,440
  • Consulting for Spinraza · 2020-12-03 · $2,400
Novartis Gene Therapies Inc. (fka AveXis Inc.)Zolgensma$1,385
1 payment
  • Honoraria for Zolgensma · 2020-10-26 · $1,385
Genentech USANone$1,200
1 payment
  • Consulting · 2020-08-27 · $1,200
Sarepta TherapeuticsExondys 51$145
2 payments
  • Meals for Exondys 51 · 2020-02-26 · $12
  • Meals for Exondys 51 · 2020-01-23 · $133

2019: $22,842

Payments by company in 2019
BiogenSpinraza$12,837
10 payments
  • Consulting for Spinraza · 2019-09-09 · $1,866
  • Consulting for Spinraza · 2019-09-09 · $1,208
  • Consulting for Spinraza · 2019-09-09 · $5,750
  • Consulting for Spinraza · 2019-04-18 · $3,360
  • Travel for Spinraza · 2019-04-18 · $101
  • Meals for Spinraza · 2019-04-18 · $68
  • Meals for Spinraza · 2019-04-18 · $64
  • Meals for Spinraza · 2019-04-18 · $69
  • Travel for Spinraza · 2019-04-17 · $226
  • Meals for Spinraza · 2019-04-17 · $126
Sarepta TherapeuticsExondys 51$10,006
11 payments
  • Consulting for Exondys 51 · 2019-06-24 · $4,100
  • Travel for Exondys 51 · 2019-06-22 · $250
  • Travel for Exondys 51 · 2019-06-22 · $374
  • Meals for Exondys 51 · 2019-06-22 · $38
  • Meals for Exondys 51 · 2019-06-22 · $38
  • Travel for Exondys 51 · 2019-06-22 · $425
  • Meals for Exondys 51 · 2019-06-21 · $106
  • Meals for Exondys 51 · 2019-04-16 · $43
  • Meals for Exondys 51 · 2019-02-19 · $17
  • Meals for Exondys 51 · 2019-01-24 · $115
  • Consulting for Exondys 51 · 2019-01-08 · $4,500

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Sarepta Therapeutics, Inc. · 2024Their institution$199,808
Sarepta Therapeutics, Inc. · 2025Their institution$184,242
Sarepta Therapeutics, Inc. · 2023Their institution$78,373
Sarepta Therapeutics, Inc. · 2022Their institution$50,320
GENZYME CORPORATION · An Open-Label, Multinational, Multicenter, Intravenous Infusion Study of the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Avalglucosidase Alfa in Treatment Naive Pediatric Participants With Infantile-Onset Pompe Disease (Iopd) · 2024Their institution$25,675
Janssen Research & Development, LLC · A Study of Nipocalimab in Children Aged 2 To Less Than 18 Years With Generalized Myasthenia Gravis · 2025Their institution$15,873
GENZYME CORPORATION · An Open-Label, Multinational, Multicenter, Intravenous Infusion Study of the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Avalglucosidase Alfa in Treatment Naive Pediatric Participants With Infantile-Onset Pompe Disease (Iopd) · 2025Their institution$7,987
Janssen Research & Development, LLC · 2023Their institution$4,691
Janssen Research & Development, LLC · 2024Their institution$3,186
Sarepta Therapeutics, Inc. · 2023This clinician$1,971

Professional record

NPI
1255646915
Licence
CA A125750California A125750: Current · expires 2028-09-30
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 2084N0008X (2084N0008X); Federal specialty code 2084N0402X (2084N0402X)
Mailing address
300 Pasteur Dr, Palo Alto, CA, 94304
NPI first listed
2010-08-18
NPI last updated
2023-11-06
NPI record certified
2023-11-06

This is when the NPI record was last certified, not a medical board exam.